NHS Health Chief calls for return of facemasks and social distancing
April 20, 2022Research and Development
Chris Hopson, Chief Executive of NHS Providers, which represents trusts has urged ministers to discuss “sensible precautions” for the public, …
AstraZeneca drug granted FDA Priority Review
April 19, 2022Manufacturing and Production
AstraZeneca and Daiichi Sankyo have announced that the lung cancer antibody drug conjugate, Enhertu, has received Priority Review from the …
FDA accept New Drug Application for GSK’s daprodustat
April 19, 2022Manufacturing and Production
GSK has announced the FDA has accepted the New Drug Application (NDA) for daprodustat, an oral hypoxia-inducible factor prolyl hydroxylase …
VistaGen and AffaMed complete regulatory submissions for Phase III SAD trial
April 13, 2022Research and Development
VistaGen and AffaMed have announced the completion of key regulatory preparations to initiate PALISADE global, a Phase III clinical trial …
NICE recommends avelumab for urothelial cancer patients
April 13, 2022Research and Development
NICE has recommended avelumab as treatment for adults with locally advanced or metastatic urothelial cancer.The treatment, avelumab, will benefit over …
FDA and DEA warn online pharmacies illegally selling ADHD drug Adderall
April 13, 2022Research and Development
The FDA and the US DEA have jointly issued warning letters to operators of two websites illegally selling Schedule II …
It could take up to six years to clear the patient backlog in Europe
April 13, 2022Research and Development
Research has found that oncologists and surgeons across Europe estimate it will take at least three years to clear the …
Tjaopack announces completion of Netherlands facility expansion
April 12, 2022Manufacturing and Production
Tjaopack has announced the completion of its expansion plans, following a €10 million plus investment, at its Etten-Leur facility in …
Amid growing fears of antimicrobial-resistance, NHS payment scheme aims for pharma to tackle superbugs
April 12, 2022Manufacturing and Production
NICE has shared that cefiderocol, and ceftazidime/avibactam, have the potential to save lives. The two medications, which fight drug-resistant superbugs, …
VR solution for personalised treatment and surgery guidance to spine surgeons
April 12, 2022Manufacturing and Production
Seymourpowell and Axis Spine Technologies have announced a virtual reality (VR) solution allowing surgeons to evaluate and develop spinal implants …
SMC accepts Inrebic for treatment of splenomegaly and myelofibrosis
April 12, 2022The SMC has accepted Inrebic (fedratinib) for use witin NHS Scotland, for the treatment of disease-related splenomegaly (enlarged spleen). It …
Recipharm announces closing of acquisitions of two major CDMOs
April 11, 2022Sales and Marketing
Recipharm has announced the closing of its acquisitions of advanced therapy CDMO Arranta Bio and virotherapy CDMO Vibalogics. The acquisitions …
Innovative therapy ‘tricks’ and destroys cancer cells
April 11, 2022Sales and Marketing
A novel therapy studied at the Medical College of Wisconsin (MCW) Cancer Centre is headed for clinical trial in patients …
World leaders pledge $4.8 billion in 2022 Break COVID Now Summit
April 11, 2022Sales and Marketing
World leaders in Germany, Ghana, Indonesia, and Senegal came together in the 2022 Break COVID Now Summit, co-hosted by vaccine …
‘Killer’ immunotherapy shows early promise
April 11, 2022Sales and Marketing
A first of its kind immunotherapy which uses the immune system’s ‘natural killer cells’ could offer potential against a range …
NICE publishes guidance for atopic dermatitis treatments
April 8, 2022Medical Communications
Abrocitinib, upadacitinib, and tralokinumab are not recommended for treating moderate to severe atopic dermatitis. The recommendation does not affect patients …
First-of-its-kind vaccine manufacturing facility shipped to Africa
April 8, 2022Medical Communications
KeyPlants announced the shipping a first-of-its-kind vaccine manufacturing filling facility to Senegal, in West Africa.
Acadia seeks first-ever FDA approval in Rett Syndrome
April 8, 2022Medical Communications
Acadia has presented an update on its Phase III LAVENDER study of trofinetide for Rett Syndrome at the American Academy …
Kintor’s antiviral shows protection in mild-to-moderate COVID-19
April 7, 2022Business Services
Kintor Pharmaceutical, based in Suzhou, China, has announced top-line results from its Phase III MRCT trial of proxalutamide in outpatients …
